But new research has concluded that this reduction may not have been a result of the change in the law. The study, by Oliver Morgan and colleagues from the Department of Primary Care and Social Medicine, Imperial College London, United Kingdom and the UK Office for National Statistics, is published in the latest issue of PLoS Medicine.
Paracetamol is a cheap and effective pain-killer but overdoses (accidental or deliberate) can be fatal. Many suicide attempts involve paracetamol and it is the commonest cause of acute liver failure in many countries. In the UK, since 1998, pharmacies have not been permitted to sell packs of paracetamol containing more than 32 tablet, and other shops cannot sell packs with more than 16 tablets. Using data from the UK Office for National Statistics, the researchers established that, in England and Wales, the average number of deaths in the five years preceding the regulation was 212/year and in the following five years it fell to an average of 154/year. However, in addition, they found that the number of deaths per year involving any drug – and also ‘non-drug’ suicides – fell during the same period of time. When comparing the trends for paracetamol deaths with other poisoning or suicide deaths, the research ers did not find any statistical evidence that the fall in paracetamol deaths was any different to the overall decline in poisoning or suicide death rates in England and Wales.
The implications of the study are further discussed, in the same issue of PLoS Medicine, by a toxicologist, Professor Nick Buckley (Australian National University Medical School) and David Buckley (University of Bristol, UK). In their view, “It seems most likely that the pack size regulations did change the pattern of paracetamol poisoning but that changes were far more modest than hoped.” Like the authors of the research, they say it is important that, whenever public health legislation is introduced, the impact should be properly evaluated.
CONTACT:
Oliver Morgan
Imperial College London
Primary Care and Social Medicine
Charing Cross Hospital
London, London W6 8RP
United Kingdom
omorgan@bigfoot.com
Andrew Hyde | Source: alphagalileo
Further information: www.plosmedicine.org
medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040105
More articles from Studies and Analyses:
Study Shows Sweetener Marketing Tactics May Mislead Consumers
20.11.2009 | Corn Refiners Association
Debt Stress Drops for Third Straight Month, Survey Finds
20.11.2009 | Ohio State University
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News